These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19295616)

  • 1. Differential effects of corticosteroids and pimecrolimus on the developing skin immune system in humans and mice.
    Meindl S; Vaculik C; Meingassner JG; Kramer G; Akgün J; Prior M; Stuetz A; Stingl G; Elbe-Bürger A
    J Invest Dermatol; 2009 Sep; 129(9):2184-92. PubMed ID: 19295616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells.
    Hoetzenecker W; Meingassner JG; Ecker R; Stingl G; Stuetz A; Elbe-Bürger A
    J Invest Dermatol; 2004 Mar; 122(3):673-84. PubMed ID: 15086553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
    Hoetzenecker W; Ecker R; Kopp T; Stuetz A; Stingl G; Elbe-Bürger A
    J Allergy Clin Immunol; 2005 Jun; 115(6):1276-83. PubMed ID: 15940147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development and pre-clinical aspects of pimecrolimus].
    Stütz A; Grassberger M; Meingassner JG
    Hautarzt; 2003 May; 54(5):405-12. PubMed ID: 12719859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pimecrolimus does not affect Langerhans cells in murine epidermis.
    Meingassner JG; Kowalsky E; Schwendinger H; Elbe-Bürger A; Stütz A
    Br J Dermatol; 2003 Oct; 149(4):853-7. PubMed ID: 14616380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis.
    Jensen JM; Scherer A; Wanke C; Bräutigam M; Bongiovanni S; Letzkus M; Staedtler F; Kehren J; Zuehlsdorf M; Schwarz T; Weichenthal M; Fölster-Holst R; Proksch E
    Allergy; 2012 Mar; 67(3):413-23. PubMed ID: 22142306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial.
    Sigurgeirsson B; Boznanski A; Todd G; Vertruyen A; Schuttelaar ML; Zhu X; Schauer U; Qaqundah P; Poulin Y; Kristjansson S; von Berg A; Nieto A; Boguniewicz M; Paller AS; Dakovic R; Ring J; Luger T
    Pediatrics; 2015 Apr; 135(4):597-606. PubMed ID: 25802354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids.
    Jensen JM; Ahrens K; Meingassner J; Scherer A; Bräutigam M; Stütz A; Schwarz T; Fölster-Holst R; Harder J; Gläser R; Proksch E
    Exp Dermatol; 2011 Oct; 20(10):783-8. PubMed ID: 21707760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
    Sugita K; Kabashima K; Atarashi K; Shimauchi T; Kobayashi M; Tokura Y
    Clin Exp Immunol; 2007 Jan; 147(1):176-83. PubMed ID: 17177977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical pimecrolimus 1% reverses long-term suberythemal ultraviolet B-induced epidermal Langerhans cell reduction and morphologic changes in mice.
    Yin Z; Xu J; Lu Y; Luo D
    J Drugs Dermatol; 2012 Sep; 11(9):e25-7. PubMed ID: 23135668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
    Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
    BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
    Stuetz A; Baumann K; Grassberger M; Wolff K; Meingassner JG
    Int Arch Allergy Immunol; 2006; 141(3):199-212. PubMed ID: 16926539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).
    Panhans-Gross A; Novak N; Kraft S; Bieber T
    J Allergy Clin Immunol; 2001 Feb; 107(2):345-52. PubMed ID: 11174203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography.
    Aschoff R; Schmitt J; Knuschke P; Koch E; Bräutigam M; Meurer M
    Exp Dermatol; 2011 Oct; 20(10):832-6. PubMed ID: 21771098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pimecrolimus versus triamcinolone on Langerhans cells after UV exposure.
    Martires KJ; Domingo DS; Hsia A; Fu P; Cooper KD; Baron ED
    Exp Dermatol; 2011 Mar; 20(3):280-2. PubMed ID: 21166722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids.
    Kalthoff FS; Chung J; Musser P; Stuetz A
    Clin Exp Immunol; 2003 Sep; 133(3):350-9. PubMed ID: 12930360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
    Grassberger M; Steinhoff M; Schneider D; Luger TA
    Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.